These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11256 related articles for article (PubMed ID: 10685653)

  • 61. New approaches to the systemic treatment of melanoma.
    Chowdhury S; Vaughan MM; Gore ME
    Cancer Treat Rev; 1999 Oct; 25(5):259-70. PubMed ID: 10544070
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biochemotherapy of melanoma.
    Flaherty LE; Gadgeel SM
    Semin Oncol; 2002 Oct; 29(5):446-55. PubMed ID: 12407509
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biochemotherapy for melanoma.
    Philip PA; Flaherty LE
    Curr Oncol Rep; 2000 Jul; 2(4):314-21. PubMed ID: 11122859
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma.
    Recchia F; Candeloro G; Necozione S; Fumagalli L; Bratta M; Rea S
    Anticancer Drugs; 2008 Feb; 19(2):201-7. PubMed ID: 18176117
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical results using biochemotherapy as a standard of care in advanced melanoma.
    Chapman PB; Panageas KS; Williams L; Wolchok JD; Livingston PO; Quinn C; Hwu WJ
    Melanoma Res; 2002 Aug; 12(4):381-7. PubMed ID: 12170188
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy.
    Tarhini AA; Kirkwood JM; Gooding WE; Cai C; Agarwala SS
    J Clin Oncol; 2007 Sep; 25(25):3802-7. PubMed ID: 17761969
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tamoxifen in the treatment of metastatic malignant melanoma: still a controversy? (Review).
    Toma S; Ugolini D; Palumbo R
    Int J Oncol; 1999 Aug; 15(2):321-37. PubMed ID: 10402244
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
    Kim KB; Legha SS; Gonzalez R; Anderson CM; Johnson MM; Liu P; Papadopoulos NE; Eton O; Plager C; Buzaid AC; Prieto VG; Hwu WJ; Frost AM; Alvarado G; Hwu P; Ross MI; Gershenwald JE; Lee JE; Mansfield PF; Benjamin RS; Bedikian AY
    Melanoma Res; 2009 Feb; 19(1):42-9. PubMed ID: 19430405
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interferon alfa for the treatment of follicular lymphomas.
    Hiddemann W; Griesinger F; Unterhalt M
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S13-8. PubMed ID: 9672770
    [TBL] [Abstract][Full Text] [Related]  

  • 70. DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma.
    Buzaid AC; Ali-Osman F; Akande N; Grimm EA; Lee JJ; Bedikian A; Eton O; Papadopoulos N; Plager C; Legha SS; Benjamin RS
    Melanoma Res; 1998 Apr; 8(2):145-8. PubMed ID: 9610867
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of metastatic malignant melanoma.
    Atallah E; Flaherty L
    Curr Treat Options Oncol; 2005 May; 6(3):185-93. PubMed ID: 15869730
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Treatment of malignant melanoma: recent advances and perspectives].
    Saida T
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):10-5. PubMed ID: 9020939
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial.
    Ridolfi R; Chiarion-Sileni V; Guida M; Romanini A; Labianca R; Freschi A; Lo Re G; Nortilli R; Brugnara S; Vitali P; Nanni O;
    J Clin Oncol; 2002 Mar; 20(6):1600-7. PubMed ID: 11896110
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?
    Bedikian AY; Johnson MM; Warneke CL; Papadopoulos NE; Kim KB; Hwu WJ; McIntyre S; Rohlfs M; Homsi J; Hwu P
    Melanoma Res; 2011 Feb; 21(1):84-90. PubMed ID: 21102360
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Subcutaneous interleukin-2 and interferon-alpha therapy associated with cisplatin monochemotherapy in the treatment of metastatic melanoma.
    Andrès P; Cupissol D; Guillot B; Avril MF; Drèno B
    Eur J Dermatol; 1998 Jun; 8(4):235-9. PubMed ID: 9649695
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-alpha in patients with metastatic melanoma.
    González Cao M; Malvehy J; Martí R; Conill C; Sánchez M; Martín M; Carrera C; Herrero J; Gascón P; Mellado B; Castel T; Puig S
    Melanoma Res; 2006 Feb; 16(1):59-64. PubMed ID: 16432457
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metastatic melanoma: chemotherapy to biochemotherapy.
    O'Day SJ; Kim CJ; Reintgen DS
    Cancer Control; 2002; 9(1):31-8. PubMed ID: 11907464
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.
    Rosenberg SA; Yang JC; Schwartzentruber DJ; Hwu P; Marincola FM; Topalian SL; Seipp CA; Einhorn JH; White DE; Steinberg SM
    J Clin Oncol; 1999 Mar; 17(3):968-75. PubMed ID: 10071291
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, temozolomide (Temodal), interferon-alfa and interleukin-2 for metastatic melanoma: a phase II study.
    Ron IG; Sarid D; Ryvo L; Sapir EE; Schneebaum S; Metser U; Asna N; Inbar MJ; Safra T
    Melanoma Res; 2006 Feb; 16(1):65-9. PubMed ID: 16432458
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metastatic melanoma.
    Sun W; Schuchter LM
    Curr Treat Options Oncol; 2001 Jun; 2(3):193-202. PubMed ID: 12057119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 563.